Skip to main content
. 2022 Jul 14;13:918212. doi: 10.3389/fendo.2022.918212

Figure 6.

Figure 6

Analysis of master regulators in the 20-29 age group vs. the 30-39 age group. (A) Top 20 transcription factors with differential protein activity enrichment (B–D) Significantly activated transcription factors in the 30-39 age group for the diagnosis of ovarian senescence in the reproductive years (VAV1, RUNX3, IRF5). (E–G) Significantly activated transcription factors in the 20-29 age group for the diagnosis of ovarian senescence in the reproductive age group (KDM1A, PRDM5, ZNF726). Act: TF activation; Exp: TF expression.